SlideShare a Scribd company logo
A SMART ALTERNATIVE FOR
SPECIMEN COLLECTION
A new model using the LabCorp network of Patient Service Centers (PSCs) for sample collection
visits can reduce the amount of patient travel required for participation in your trials, making
them more efficient and accessible to potential enrollees.
Based on a recent survey, the average distance a patient has to travel to a clinical trial investigator
site is more than 25 miles.* The burden that this travel to investigator sites places on patients is
widely recognized as being a major barrier to patient participation in clinical trials.
Because the PSC network has >1,800 locations across the United States, the survey showed that
on average there was a PSC within about 3 miles of the patients’ homes and >75% of the patients
had at least one PSC within 10 miles.
Quick Facts About PSC Sample Collection Visits:
▸▸ PSCs support diverse sample collection capabilities, and most can support collection of
biometric data
▸▸ Your specimens will be shipped to our central laboratory for testing, delivering results
combinable with all other testing in your trial
▸▸ Data reporting and alerts will occur using the same tools and processes as for samples
collected at investigator sites, for a seamless experience
*Based on >600 US trial participants surveyed in 2018 by Covance
75
75
INVESTIGATOR SITE
AVERAGE TRAVEL DISTANCE (MILES)
0 5 10 15 20 25
PSC
Patient Service Center Visits
Learn more about how PSC visits are more convenient for your patients and require
less investigator time for routine collection visits at www.covance.com/psc
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory
Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the
marketing name for Covance Inc. and its subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623)  +1.609.452.4440
Europe/Africa  +00.800.2682.2682 +44.1423.500888
Asia Pacific  +800.6568.3000 +65.6.5686588
© Copyright 2019 Covance Inc. SSCLS048-0119
Bring Your Studies to Your Patients with PSC Visits
Statistics show that only 10-20% of trials meet their enrollment timelines, while 86% of clinical trials don’t
finish on time.* Reducing patient burden can significantly improve enrollment and retention.
The use of PSC visits as an alternative for trips to investigator sites, appropriate when the visit is only for
sample collection without the need for medical evaluation or intervention, reduces the total travel burden and
thus makes trials more accessible to patients. This could be a key advantage for your trial in several cases:
▸▸ Extremely ill or immobilized patients for whom travel poses a severe challenge or risk, so that lengthy
travel to investigator sites is reserved for those visits that are medically necessary
▸▸ Trials involving widely dispersed populations where many of the visits are for routine sample collection
▸▸ Long-term follow-up of Phase I trial populations after they have left the trial clinic and may even have
moved out of the area
Flexibility for Your Studies. And Your Patients.
Covance solutions can help you engage and enroll enough patients to deliver statistically powerful safety and
efficacy data. Even if only a small portion of your trial’s visits occur in a local PSC setting, you can expect a
favorable change in patient engagement.
As part of this solution, we can work with you, your investigator sites and your patients to ensure the PSC
visits in your trial go smoothly. This includes visit scheduling at the PSC closest to the patient’s home or
work via our call center, supplying requisition packets to the patient and even working with sponsor-chosen
vendors. All of these factors improve patient communication and engagement, aiding protocol adherence.
Uniform Testing. Exceptional Consistency. Combinable Data.
Covance and LabCorp have established processes to ensure that results from visits using PSC sample
collection and those from traditional investigator site visits will be fully combinable.
We provide globally unified Standard Operating Procedures, reagents and instrumentation. No matter where
the specimens are collected, they are processed and tested in our Indianapolis central laboratory or sent
out for external specialty testing using the same rigorous, trusted processes that deliver data that stands
up to regulatory scrutiny. The results are uniformly reported to sponsors and sites regardless of collection
methodology. And since investigators are not responsible for managing collections at our PSCs, sites will
benefit from reduced time spent on administrative tasks and greater time spent caring for patients.
*Based on Centerwatch Surveys (2012), NIH Report (2013), and ClinicalLeader.com

More Related Content

What's hot

Professor Tony Marson - International Business Festival 2018
Professor Tony Marson - International Business Festival 2018Professor Tony Marson - International Business Festival 2018
Professor Tony Marson - International Business Festival 2018
Innovation Agency
 
Patient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityPatient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient Centricity
DayOne
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
Randox
 
Poct in your pediatric OPD practice
Poct in your pediatric OPD practicePoct in your pediatric OPD practice
Poct in your pediatric OPD practice
Gaurav Gupta
 
AWARE - Providin High Value
AWARE - Providin High ValueAWARE - Providin High Value
AWARE - Providin High Value
AWARE Just Clinical
 
Interview_CenterWatch_Centralized Monitoring
Interview_CenterWatch_Centralized MonitoringInterview_CenterWatch_Centralized Monitoring
Interview_CenterWatch_Centralized Monitoring
Ashok Ghone, Ph.D.
 
NHS Eastern Cheshire CCG Deepdive presentation GBAF17
NHS Eastern Cheshire CCG Deepdive presentation GBAF17 NHS Eastern Cheshire CCG Deepdive presentation GBAF17
NHS Eastern Cheshire CCG Deepdive presentation GBAF17
Matthew Cunningham
 
Real-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. InfographicReal-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. Infographic
Covance
 
The CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory AffairsThe CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory Affairs
Medpace
 
MBA Final Poster V14
MBA Final Poster V14MBA Final Poster V14
MBA Final Poster V14
Breanna Rinaldo
 
Making surgical practice improvement easy
Making surgical practice improvement easyMaking surgical practice improvement easy
Making surgical practice improvement easy
Health Informatics New Zealand
 
Theranos Biz Model
Theranos Biz ModelTheranos Biz Model
Theranos Biz Model
Jeffrey Funk Business Models
 
Transparency Life Sciences
Transparency Life SciencesTransparency Life Sciences
Transparency Life Sciences
DayOne
 
Team 5-Final Project
Team 5-Final ProjectTeam 5-Final Project
Team 5-Final Project
Jayesh Samyani
 
NHS experience with the EQ-5D as an Outcome Measure
NHS experience with the EQ-5D as an Outcome MeasureNHS experience with the EQ-5D as an Outcome Measure
NHS experience with the EQ-5D as an Outcome Measure
Office of Health Economics
 
Varian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, OxfordVarian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, Oxford
GenesisCareUK
 
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data SharingPlacebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
TransCelerate
 
#HCAQofQ Dr Murray Ellender
#HCAQofQ Dr Murray Ellender#HCAQofQ Dr Murray Ellender
#HCAQofQ Dr Murray Ellender
Rebecca Pullen
 
Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...
Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...
Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...
HCA Healthcare UK
 
Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...
drucsamal
 

What's hot (20)

Professor Tony Marson - International Business Festival 2018
Professor Tony Marson - International Business Festival 2018Professor Tony Marson - International Business Festival 2018
Professor Tony Marson - International Business Festival 2018
 
Patient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityPatient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient Centricity
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
 
Poct in your pediatric OPD practice
Poct in your pediatric OPD practicePoct in your pediatric OPD practice
Poct in your pediatric OPD practice
 
AWARE - Providin High Value
AWARE - Providin High ValueAWARE - Providin High Value
AWARE - Providin High Value
 
Interview_CenterWatch_Centralized Monitoring
Interview_CenterWatch_Centralized MonitoringInterview_CenterWatch_Centralized Monitoring
Interview_CenterWatch_Centralized Monitoring
 
NHS Eastern Cheshire CCG Deepdive presentation GBAF17
NHS Eastern Cheshire CCG Deepdive presentation GBAF17 NHS Eastern Cheshire CCG Deepdive presentation GBAF17
NHS Eastern Cheshire CCG Deepdive presentation GBAF17
 
Real-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. InfographicReal-Time Data. Real-World Impact. Infographic
Real-Time Data. Real-World Impact. Infographic
 
The CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory AffairsThe CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory Affairs
 
MBA Final Poster V14
MBA Final Poster V14MBA Final Poster V14
MBA Final Poster V14
 
Making surgical practice improvement easy
Making surgical practice improvement easyMaking surgical practice improvement easy
Making surgical practice improvement easy
 
Theranos Biz Model
Theranos Biz ModelTheranos Biz Model
Theranos Biz Model
 
Transparency Life Sciences
Transparency Life SciencesTransparency Life Sciences
Transparency Life Sciences
 
Team 5-Final Project
Team 5-Final ProjectTeam 5-Final Project
Team 5-Final Project
 
NHS experience with the EQ-5D as an Outcome Measure
NHS experience with the EQ-5D as an Outcome MeasureNHS experience with the EQ-5D as an Outcome Measure
NHS experience with the EQ-5D as an Outcome Measure
 
Varian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, OxfordVarian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, Oxford
 
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data SharingPlacebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
Placebo and Standard of Care Data Sharing Initiative - PSoC Data Sharing
 
#HCAQofQ Dr Murray Ellender
#HCAQofQ Dr Murray Ellender#HCAQofQ Dr Murray Ellender
#HCAQofQ Dr Murray Ellender
 
Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...
Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...
Question of Quality Conference 2016 - Healthcare Technology - Exploring new m...
 
Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...
 

Similar to A Smart Alternative For Specimen Collection - Patient Service Center Visits

Real-Time Data. Real-World Impact Brochure
Real-Time Data. Real-World Impact Brochure Real-Time Data. Real-World Impact Brochure
Real-Time Data. Real-World Impact Brochure
Covance
 
Clinical Trials Portal - Cancer Institute NSW
Clinical Trials Portal - Cancer Institute NSWClinical Trials Portal - Cancer Institute NSW
Clinical Trials Portal - Cancer Institute NSW
Cancer Institute NSW
 
Why Devolution Is Clinical Trials' Best Chance of Success.pdf
Why Devolution Is Clinical Trials' Best Chance of Success.pdfWhy Devolution Is Clinical Trials' Best Chance of Success.pdf
Why Devolution Is Clinical Trials' Best Chance of Success.pdf
Sollers College
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Covance
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Covance
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
Randox
 
Build a Path to Success and Accelerate Your NASH Trials
Build a Path to Success and Accelerate Your NASH Trials Build a Path to Success and Accelerate Your NASH Trials
Build a Path to Success and Accelerate Your NASH Trials
Covance
 
Putting the Oncology Patient First
Putting the Oncology Patient FirstPutting the Oncology Patient First
Putting the Oncology Patient First
CRF Health
 
Point Of Care Testing
Point Of Care TestingPoint Of Care Testing
Point Of Care Testing
LAB IDEA
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
Hadas Jacoby
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_Sundgren
Mats Sundgren
 
Oncology PRA Health Sciences
Oncology PRA Health SciencesOncology PRA Health Sciences
Oncology PRA Health Sciences
Suzanne Curtis 248-952-2600
 
How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?
Randox
 
Study Design to Support Reimbursement
Study Design to Support ReimbursementStudy Design to Support Reimbursement
Study Design to Support Reimbursement
Lyssa Friedman
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10
Lyssa Friedman
 
Test Utilization White Paper
Test Utilization White PaperTest Utilization White Paper
Test Utilization White Paper
Gary Weiland
 
Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...
Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...
Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...
Wes Wheeler
 
Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...
Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...
Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...
Covance
 
Launch of updated Cervical Screening Programme sample taker e-learning module
Launch of updated Cervical Screening Programme sample taker e-learning moduleLaunch of updated Cervical Screening Programme sample taker e-learning module
Launch of updated Cervical Screening Programme sample taker e-learning module
PHEScreening
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
clarebernice
 

Similar to A Smart Alternative For Specimen Collection - Patient Service Center Visits (20)

Real-Time Data. Real-World Impact Brochure
Real-Time Data. Real-World Impact Brochure Real-Time Data. Real-World Impact Brochure
Real-Time Data. Real-World Impact Brochure
 
Clinical Trials Portal - Cancer Institute NSW
Clinical Trials Portal - Cancer Institute NSWClinical Trials Portal - Cancer Institute NSW
Clinical Trials Portal - Cancer Institute NSW
 
Why Devolution Is Clinical Trials' Best Chance of Success.pdf
Why Devolution Is Clinical Trials' Best Chance of Success.pdfWhy Devolution Is Clinical Trials' Best Chance of Success.pdf
Why Devolution Is Clinical Trials' Best Chance of Success.pdf
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
 
Build a Path to Success and Accelerate Your NASH Trials
Build a Path to Success and Accelerate Your NASH Trials Build a Path to Success and Accelerate Your NASH Trials
Build a Path to Success and Accelerate Your NASH Trials
 
Putting the Oncology Patient First
Putting the Oncology Patient FirstPutting the Oncology Patient First
Putting the Oncology Patient First
 
Point Of Care Testing
Point Of Care TestingPoint Of Care Testing
Point Of Care Testing
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_Sundgren
 
Oncology PRA Health Sciences
Oncology PRA Health SciencesOncology PRA Health Sciences
Oncology PRA Health Sciences
 
How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?
 
Study Design to Support Reimbursement
Study Design to Support ReimbursementStudy Design to Support Reimbursement
Study Design to Support Reimbursement
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10
 
Test Utilization White Paper
Test Utilization White PaperTest Utilization White Paper
Test Utilization White Paper
 
Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...
Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...
Pharma Almanac Q1 2016 Clinical Logistics - Meeting the 21st Century Cures Ch...
 
Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...
Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...
Improving Study Start Up and Recruitment for a Drug-Device Clinical Trial Cas...
 
Launch of updated Cervical Screening Programme sample taker e-learning module
Launch of updated Cervical Screening Programme sample taker e-learning moduleLaunch of updated Cervical Screening Programme sample taker e-learning module
Launch of updated Cervical Screening Programme sample taker e-learning module
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
 

More from Covance

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Covance
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
Covance
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Covance
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
Covance
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
Covance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
Covance
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
Covance
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
Covance
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
Covance
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
Covance
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
Covance
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Covance
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Covance
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
Covance
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
Covance
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
Covance
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
Covance
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
Covance
 
K-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH LegislationK-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH Legislation
Covance
 

More from Covance (20)

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
 
K-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH LegislationK-REACH - How to Prepare for the K-REACH Legislation
K-REACH - How to Prepare for the K-REACH Legislation
 

Recently uploaded

Navigating Change Strategies for Effective Transition and Operational Plannin...
Navigating Change Strategies for Effective Transition and Operational Plannin...Navigating Change Strategies for Effective Transition and Operational Plannin...
Navigating Change Strategies for Effective Transition and Operational Plannin...
Brian Frerichs
 
MEA Union Budget 2024-25 Final Presentation
MEA Union Budget 2024-25 Final PresentationMEA Union Budget 2024-25 Final Presentation
MEA Union Budget 2024-25 Final Presentation
PhysicsUtu
 
Top Digital Marketing Strategy in 2024.pdf
Top Digital Marketing Strategy in 2024.pdfTop Digital Marketing Strategy in 2024.pdf
Top Digital Marketing Strategy in 2024.pdf
Top IT Marketing
 
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptxThe-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
Jindal Global University, Sonipat Haryana 131001
 
Unveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdf
Unveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdfUnveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdf
Unveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdf
Xtreame HDTV
 
TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...
TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...
TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...
kevinkariuki227
 
Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...
Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...
Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...
itnewsafrica
 
High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...
High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...
High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...
dimplekumaridk322
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
Western Alaska Minerals Corp.
 
United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...
United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...
United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...
Newman George Leech
 
Patrick Dwyer Merrill Lynch - Founder of the Dwyer Family Foundation
Patrick Dwyer Merrill Lynch - Founder of the Dwyer Family FoundationPatrick Dwyer Merrill Lynch - Founder of the Dwyer Family Foundation
Patrick Dwyer Merrill Lynch - Founder of the Dwyer Family Foundation
Patrick Dwyer Merrill Lynch
 
شركات إبراهيم العرجاني: لدعم الاقتصاد المصري
شركات إبراهيم العرجاني: لدعم الاقتصاد المصريشركات إبراهيم العرجاني: لدعم الاقتصاد المصري
شركات إبراهيم العرجاني: لدعم الاقتصاد المصري
إبراهيم العرجاني
 
Satta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatkaSatta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatka
➑➌➋➑➒➎➑➑➊➍
 
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological StyleZodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
my Pandit
 
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Philip M Caputo
 
Green Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdfGreen Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdf
shivamkush646
 
PAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAA
PAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAAPAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAA
PAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAA
lawrenceads01
 
Retail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slidesRetail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slides
JairSemexant
 
foodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docxfoodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docx
PraghyaBhandari
 
TALENT ACQUISITION AND MANAGEMENT LECTURE 5
TALENT ACQUISITION AND MANAGEMENT LECTURE 5TALENT ACQUISITION AND MANAGEMENT LECTURE 5
TALENT ACQUISITION AND MANAGEMENT LECTURE 5
projectseasy
 

Recently uploaded (20)

Navigating Change Strategies for Effective Transition and Operational Plannin...
Navigating Change Strategies for Effective Transition and Operational Plannin...Navigating Change Strategies for Effective Transition and Operational Plannin...
Navigating Change Strategies for Effective Transition and Operational Plannin...
 
MEA Union Budget 2024-25 Final Presentation
MEA Union Budget 2024-25 Final PresentationMEA Union Budget 2024-25 Final Presentation
MEA Union Budget 2024-25 Final Presentation
 
Top Digital Marketing Strategy in 2024.pdf
Top Digital Marketing Strategy in 2024.pdfTop Digital Marketing Strategy in 2024.pdf
Top Digital Marketing Strategy in 2024.pdf
 
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptxThe-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
The-Three-Pillars-of-Doctoral-Research-What-Why-and-How (1).pptx
 
Unveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdf
Unveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdfUnveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdf
Unveiling the Latest Eternal IPTV Features for Seamless Streaming in 2024.pdf
 
TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...
TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...
TEST BANK For Auditing & Assurance Services A Systematic Approach, 12th Editi...
 
Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...
Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...
Anton Grutzmache- Ominisient: The Data Revolution in Banking: From Scoring Cr...
 
High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...
High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...
High Profile Girls Call Bhubaneswar 🎈🔥000XX00000 🔥💋🎈 Provide Best And Top Gir...
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
 
United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...
United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...
United Kingdom's Real Estate Mogul: Newman George Leech's Impact on the Swiss...
 
Patrick Dwyer Merrill Lynch - Founder of the Dwyer Family Foundation
Patrick Dwyer Merrill Lynch - Founder of the Dwyer Family FoundationPatrick Dwyer Merrill Lynch - Founder of the Dwyer Family Foundation
Patrick Dwyer Merrill Lynch - Founder of the Dwyer Family Foundation
 
شركات إبراهيم العرجاني: لدعم الاقتصاد المصري
شركات إبراهيم العرجاني: لدعم الاقتصاد المصريشركات إبراهيم العرجاني: لدعم الاقتصاد المصري
شركات إبراهيم العرجاني: لدعم الاقتصاد المصري
 
Satta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatkaSatta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatka
 
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological StyleZodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
 
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
 
Green Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdfGreen Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdf
 
PAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAA
PAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAAPAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAA
PAWFESSIONAL ELVA MAX.pdfAAAAAAAAAAAAAAAAAAA
 
Retail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slidesRetail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slides
 
foodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docxfoodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docx
 
TALENT ACQUISITION AND MANAGEMENT LECTURE 5
TALENT ACQUISITION AND MANAGEMENT LECTURE 5TALENT ACQUISITION AND MANAGEMENT LECTURE 5
TALENT ACQUISITION AND MANAGEMENT LECTURE 5
 

A Smart Alternative For Specimen Collection - Patient Service Center Visits

  • 1. A SMART ALTERNATIVE FOR SPECIMEN COLLECTION A new model using the LabCorp network of Patient Service Centers (PSCs) for sample collection visits can reduce the amount of patient travel required for participation in your trials, making them more efficient and accessible to potential enrollees. Based on a recent survey, the average distance a patient has to travel to a clinical trial investigator site is more than 25 miles.* The burden that this travel to investigator sites places on patients is widely recognized as being a major barrier to patient participation in clinical trials. Because the PSC network has >1,800 locations across the United States, the survey showed that on average there was a PSC within about 3 miles of the patients’ homes and >75% of the patients had at least one PSC within 10 miles. Quick Facts About PSC Sample Collection Visits: ▸▸ PSCs support diverse sample collection capabilities, and most can support collection of biometric data ▸▸ Your specimens will be shipped to our central laboratory for testing, delivering results combinable with all other testing in your trial ▸▸ Data reporting and alerts will occur using the same tools and processes as for samples collected at investigator sites, for a seamless experience *Based on >600 US trial participants surveyed in 2018 by Covance 75 75 INVESTIGATOR SITE AVERAGE TRAVEL DISTANCE (MILES) 0 5 10 15 20 25 PSC Patient Service Center Visits
  • 2. Learn more about how PSC visits are more convenient for your patients and require less investigator time for routine collection visits at www.covance.com/psc Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world. The Americas +1.888.COVANCE (+1.888.268.2623)  +1.609.452.4440 Europe/Africa  +00.800.2682.2682 +44.1423.500888 Asia Pacific  +800.6568.3000 +65.6.5686588 © Copyright 2019 Covance Inc. SSCLS048-0119 Bring Your Studies to Your Patients with PSC Visits Statistics show that only 10-20% of trials meet their enrollment timelines, while 86% of clinical trials don’t finish on time.* Reducing patient burden can significantly improve enrollment and retention. The use of PSC visits as an alternative for trips to investigator sites, appropriate when the visit is only for sample collection without the need for medical evaluation or intervention, reduces the total travel burden and thus makes trials more accessible to patients. This could be a key advantage for your trial in several cases: ▸▸ Extremely ill or immobilized patients for whom travel poses a severe challenge or risk, so that lengthy travel to investigator sites is reserved for those visits that are medically necessary ▸▸ Trials involving widely dispersed populations where many of the visits are for routine sample collection ▸▸ Long-term follow-up of Phase I trial populations after they have left the trial clinic and may even have moved out of the area Flexibility for Your Studies. And Your Patients. Covance solutions can help you engage and enroll enough patients to deliver statistically powerful safety and efficacy data. Even if only a small portion of your trial’s visits occur in a local PSC setting, you can expect a favorable change in patient engagement. As part of this solution, we can work with you, your investigator sites and your patients to ensure the PSC visits in your trial go smoothly. This includes visit scheduling at the PSC closest to the patient’s home or work via our call center, supplying requisition packets to the patient and even working with sponsor-chosen vendors. All of these factors improve patient communication and engagement, aiding protocol adherence. Uniform Testing. Exceptional Consistency. Combinable Data. Covance and LabCorp have established processes to ensure that results from visits using PSC sample collection and those from traditional investigator site visits will be fully combinable. We provide globally unified Standard Operating Procedures, reagents and instrumentation. No matter where the specimens are collected, they are processed and tested in our Indianapolis central laboratory or sent out for external specialty testing using the same rigorous, trusted processes that deliver data that stands up to regulatory scrutiny. The results are uniformly reported to sponsors and sites regardless of collection methodology. And since investigators are not responsible for managing collections at our PSCs, sites will benefit from reduced time spent on administrative tasks and greater time spent caring for patients. *Based on Centerwatch Surveys (2012), NIH Report (2013), and ClinicalLeader.com